The Neglected Role of Psychotherapy for Treatment-Resistant Depression

Dr. Markowitz receives consultation fees from the U.S. Department of Defense and NIMH and royalties from American Psychiatric Association Publishing, Basic Books, and Oxford University Press. Dr. Wright reports equity interest and consulting with Mindstreet, Inc., and royalties from American Psychiatric Association Publishing, Guilford Press, and Simon and Schuster. Dr. Peeters receives royalties from Boom Publishers, Bohn Stafleu van Loghum, and Hogrefe Publishing Group, receives research grants from Zon-MW and the Mitialto Foundation, and received financial compensation as an independent symposium speaker for Janssen-Cilag and SCEM. Dr. Thase has served as an adviser or consultant for Acadia, Akili, Alkermes, Allergan (Forest, Naurex), Boehringer-Ingelheim, Clexio Biosciences, H. Lundbeck A/S, Jazz Pharmaceuticals, Janssen (Johnson & Johnson), Otsuka Pharmaceutical Company, Perception Neuroscience, Sage Therapeutics, Seelos Pharmaceuticals, and Takeda; he has received grant support from Acadia, Allergan (Forest, Naurex), Axsome Therapeutics, Intracellular, Johnson & Johnson (Janssen), Myriad (Assurex), Otsuka Pharmaceutical Company, and Takeda; he receives royalties from American Psychiatric Association Publishing, Guilford Publications, Herald House, and W.W. Norton & Company; and his spouse is employed by Open Health (formerly Peloton Advantage), which does business with a number of pharmaceutical companies. Dr. Kocsis reports no conflicts of interest. Dr. Sudak receives book royalties from American Psychiatric Association Publishing, John Wiley and Sons, and Wolters-Kluwer.